| Source: |
| Type: |
| Neuroprotective refers to the ability of a substance, intervention, or strategy to preserve the structure and function of nerve cells (neurons) against injury or degeneration. -While cancer and neurodegenerative processes might seem distinct, there is significant overlap in terms of treatment-related neurotoxicity, shared molecular mechanisms, and the potential for therapies that provide neuroprotection during cancer treatment. |
| 6060- | SeNPs, | Multifunctional Selenium Quantum Dots for the Treatment of Alzheimer's Disease by Reducing Aβ-Neurotoxicity and Oxidative Stress and Alleviate Neuroinflammation |
| - | Study, | AD, | NA |
| - | Review, | AD, | NA |
| 6048- | SeNPs, | Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review |
| - | Review, | AD, | NA |
| 4721- | SeNPs, | A review on selenium nanoparticles and their biomedical applications |
| - | Review, | AD, | NA | - | Review, | Diabetic, | NA | - | Review, | Arthritis, | NA |
| 4189- | Sesame, | Sesame oil mitigates memory impairment, oxidative stress, and neurodegeneration in a rat model of Alzheimer's disease. A pivotal role of NF-κB/p38MAPK/BDNF/PPAR-γ pathways |
| - | in-vivo, | AD, | NA |
| 4199- | SFN, | Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3182- | SFN, | Sulforaphane Modulates AQP8-Linked Redox Signalling in Leukemia Cells |
| - | in-vitro, | AML, | NA |
| 3663- | SFN, | Efficacy of Sulforaphane in Neurodegenerative Diseases |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3661- | SFN, | Beneficial Effects of Sulforaphane Treatment in Alzheimer's Disease May Be Mediated through Reduced HDAC1/3 and Increased P75NTR Expression |
| - | in-vitro, | AD, | NA |
| 3660- | SFN, | Sulforaphane - role in aging and neurodegeneration |
| - | Review, | AD, | NA |
| 3658- | SFN, | Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 1724- | SFN, | Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials |
| - | Review, | Var, | NA |
| 1484- | SFN, | Sulforaphane’s Multifaceted Potential: From Neuroprotection to Anticancer Action |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 3947- | Shank, | Convolvulus pluricaulis (Shankhapushpi) ameliorates human microtubule-associated protein tau (hMAPτ) induced neurotoxicity in Alzheimer's disease Drosophila model |
| - | in-vivo, | AD, | NA |
| 3948- | Shank, | Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain |
| - | in-vivo, | AD, | NA |
| 3946- | Shank, | Phytochemical Profile, Pharmacological Attributes and Medicinal Properties of Convolvulus prostratus – A Cognitive Enhancer Herb for the Management of Neurodegenerative Etiologies |
| - | Review, | AD, | NA |
| 3944- | Shank, | Role of Shankhpushpi (Convolvulus pluricaulis) in neurological disorders: An umbrella review covering evidence from ethnopharmacology to clinical studies |
| - | Review, | AD, | NA |
| 3943- | Shank, | Protective Mechanisms of Nootropic Herb Shankhpushpi (Convolvulus pluricaulis) against Dementia: Network Pharmacology and Computational Approach |
| - | Review, | AD, | NA |
| 3331- | SIL, | The clinical anti-inflammatory effects and underlying mechanisms of silymarin |
| - | Review, | NA, | NA |
| 3330- | SIL, | Mechanistic Insights into the Pharmacological Significance of Silymarin |
| - | Review, | Var, | NA |
| 3324- | SIL, | Silymarin prevents NLRP3 inflammasome activation and protects against intracerebral hemorrhage |
| 3321- | SIL, | Silymarin (Milk thistle) |
| - | Review, | AD, | NA |
| 3320- | SIL, | Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action |
| - | Review, | AD, | NA |
| 3319- | SIL, | Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 3318- | SIL, | Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3317- | SIL, | Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer's Disease and Other Neurological Disorders |
| - | Review, | NA, | NA |
| 3316- | SIL, | Chemo, | Silymarin Nanoparticles Counteract Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights into Mitochondrial Dysfunction and Nrf2/HO-1 Axis |
| 3315- | SIL, | Silymarin alleviates docetaxel-induced central and peripheral neurotoxicity by reducing oxidative stress, inflammation and apoptosis in rats |
| - | in-vivo, | Nor, | NA |
| 3655- | SIL, | Protective effect of silymarin on oxidative stress in rat brain |
| - | in-vivo, | AD, | NA |
| 3654- | SIL, | Effect of silymarin on biochemical parameters of oxidative stress in aged and young rat brain |
| - | in-vivo, | AD, | NA |
| 3653- | SIL, | Silibinin ameliorates Aβ25-35-induced memory deficits in rats by modulating autophagy and attenuating neuroinflammation as well as oxidative stress |
| - | in-vivo, | AD, | NA |
| 3307- | SIL, | Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications |
| - | Review, | Var, | NA |
| 3294- | SIL, | Silymarin: a review on paving the way towards promising pharmacological agent |
| - | Review, | Nor, | NA | - | Review, | Arthritis, | NA |
| 3288- | SIL, | Silymarin in cancer therapy: Mechanisms of action, protective roles in chemotherapy-induced toxicity, and nanoformulations |
| - | Review, | Var, | NA |
| 4136- | Silicon, | Aluminum Should Now Be Considered a Primary Etiological Factor in Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 4134- | Silicon, | Garden Cress (Lepidium sativum) Seeds Ameliorated Aluminum-Induced Alzheimer Disease in Rats Through Antioxidant, Anti-Inflammatory, and Antiapoptotic Effects |
| - | in-vivo, | AD, | NA |
| 4133- | Silicon, | Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study |
| - | Study, | AD, | NA |
| 4131- | Silicon, | Silicon reduces aluminum accumulation in rats: relevance to the aluminum hypothesis of Alzheimer disease |
| - | Study, | Nor, | NA |
| 4125- | Silicon, | Oral silicon supplementation: an effective therapy for preventing oral aluminum absorption and retention in mammals |
| - | Review, | AD, | NA |
| 4127- | Silicon, | Interference of Parenteral Nutrition Components in Silicon-Mediated Protection Against Aluminum Bioaccumulation |
| - | in-vivo, | AD, | NA |
| 2214- | SK, | Shikonin Attenuates Cochlear Spiral Ganglion Neuron Degeneration by Activating Nrf2-ARE Signaling Pathway |
| - | in-vitro, | Nor, | NA |
| 2213- | SK, | Shikonin attenuates cerebral ischemia/reperfusion injury via inhibiting NOD2/RIP2/NF-κB-mediated microglia polarization and neuroinflammation |
| - | in-vivo, | Stroke, | NA |
| 3040- | SK, | Pharmacological Properties of Shikonin – A Review of Literature since 2002 |
| - | Review, | Var, | NA | - | Review, | IBD, | NA | - | Review, | Stroke, | NA |
| 3049- | SK, | Shikonin Attenuates Chronic Cerebral Hypoperfusion-Induced Cognitive Impairment by Inhibiting Apoptosis via PTEN/Akt/CREB/BDNF Signaling |
| - | in-vivo, | Nor, | NA | - | NA, | Stroke, | NA |
| 3050- | SK, | Systemic administration of Shikonin ameliorates cognitive impairment and neuron damage in NPSLE mice |
| - | in-vivo, | Nor, | NA |
| 4891- | Sper, | Spermidine as a promising anticancer agent: Recent advances and newer insights on its molecular mechanisms |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 4216- | SSE, | Selenium ameliorates mercuric chloride-induced brain damage through activating BDNF/TrKB/PI3K/AKT and inhibiting NF-κB signaling pathways |
| - | in-vitro, | NA, | NA |
| - | Trial, | GC, | NA |
| 4498- | SSE, | Selenium in Human Health and Gut Microflora: Bioavailability of Selenocompounds and Relationship With Diseases |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | IBD, | NA |
| 4151- | Taur, | Gins, | Taurine and Ginsenoside Rf Induce BDNF Expression in SH-SY5Y Cells: A Potential Role of BDNF in Corticosterone-Triggered Cellular Damage |
| - | in-vitro, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1105 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid